Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenoptin extension study in PKU
NCT00332189Phase 3Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Jul 2006
- Primary completion
- Aug 2009
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of sapropterin in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started Jul 2006; status: completed.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT00332189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332189.